<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04789447</url>
  </required_header>
  <id_info>
    <org_study_id>CT-19</org_study_id>
    <nct_id>NCT04789447</nct_id>
  </id_info>
  <brief_title>Initial CT Findings and CO-RADS Stage in COVID-19</brief_title>
  <official_title>Comparison of Initial CT Findings and CO-RADS Stage in COVID-19 Patients With PCR, Inflammation and Coagulation Parameters in Diagnostic and Prognostic Perspectives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine whether patients with different real-time reverse&#xD;
      transcriptase-polymerase chain reaction (PCR), chest computed tomography (CT) and laboratory&#xD;
      findings have different clinical outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to determine the rates of PCR positivity and CT findings in hospitalized&#xD;
      patients with a diagnosis of COVID-19, to determine whether there is a difference in&#xD;
      mortality and need for ICU between patients grouped according to the PCR positivity and&#xD;
      presence of CT findings, and to evaluate the effect of the CO-RADS stage on these outcomes.&#xD;
      Moreover, it is to compare the effects of inflammation and coagulation markers and CO-RADS&#xD;
      stage on the severity of the disease&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 4, 2021</start_date>
  <completion_date type="Actual">May 6, 2021</completion_date>
  <primary_completion_date type="Actual">May 6, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>up to 30 days</time_frame>
    <description>mortality during hospitalization and within 14 days after hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>need for intensive care</measure>
    <time_frame>up to 30 days</time_frame>
    <description>need for intensive care during hospitalization and within 30 days after hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for intenvasive mechanical ventilation</measure>
    <time_frame>up to 30 days</time_frame>
    <description>need for intenvasive mechanical ventilation during hospitalization and within 30 days after hospitalization</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">895</enrollment>
  <condition>Covid19</condition>
  <condition>SARS-CoV Infection</condition>
  <condition>Pneumonia, Viral</condition>
  <arm_group>
    <arm_group_label>COVID-19 patients in hospital</arm_group_label>
    <description>All patients aged 18 years and over, positive for SARS-CoV-2 PCR test and / or Covid-19 treatment with signs of Covid-19 disease on CT</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are diagnosed with Covid-19 in a two tertier hospital in Turkey&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years and over,&#xD;
&#xD;
          -  Having SARS-CoV-2 RT-PCR test and chest CT examinations performed at the time of&#xD;
             application or within 24 hours after admission&#xD;
&#xD;
          -  RT-PCR positivity in nasopharyngeal swabs sample, and/or the presence of clinical and&#xD;
             laboratory findings of SARS-CoV-2 infection and/or the presence of COVID-19-compatible&#xD;
             radiological findings in chest CT, and being diagnosed with COVID-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with negative SARS-CoV-2 PCR test, pneumonia on CT but not given Covid-19&#xD;
             treatment by not considering Covid-19 by their doctor will not be included.&#xD;
&#xD;
          -  Patients whose data are not available&#xD;
&#xD;
          -  Patients with poor CT image quality&#xD;
&#xD;
          -  Patients who were transferred to another hospital&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sultan Abdülhamid Han Training and Rsearch Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sultan Abdülhamid Han Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34660</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sultan Abdülhamid Han Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 4, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</investigator_affiliation>
    <investigator_full_name>Elif Yıldırım Ayaz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>SARS-CoV2 RT-PCR Testing</keyword>
  <keyword>Thorax</keyword>
  <keyword>Computerized Tomography</keyword>
  <keyword>Mortality</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Pneumonia, Viral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

